tetano
Editor, Senior Moderator
Clin Infect Dis. 2020 Jan 6. pii: ciaa007. doi: 10.1093/cid/ciaa007. [Epub ahead of print] [h=1]High rates of influenza-associated invasive pulmonary aspergillosis may not be universal: a retrospective cohort study from Alberta, Canada.[/h]
Schwartz IS[SUP]1[/SUP], Friedman DZP[SUP]1[/SUP], Zapernick L[SUP]1[/SUP], Dingle TC[SUP]2[/SUP], Lee N[SUP]1[/SUP], Sligl W[SUP]1,[/SUP][SUP]3[/SUP], Zelyas N[SUP]2[/SUP], Smith SW[SUP]1[/SUP].
[h=3]Author information[/h] 1 Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta. 2 Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta and Alberta Public Laboratories, Alberta Health Services. 3 Department of Critical Care Medicine, University of Alberta.
[h=3]Abstract[/h] Invasive pulmonary aspergillosis (IPA) complicated 7.2% of patients with influenza-associated respiratory failure in Edmonton, Alberta, from 2014-2019, ranging from 0-23.1% in different influenza seasons. Disease outcomes ranged from survival without therapy to death despite antifungals. Clinician vigilance, longitudinal local surveillance, and refined criteria to identify patients requiring therapy are needed.
? The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
[h=4]KEYWORDS:[/h] Aspergillus ; aspergillosis; emerging infections; influenza; intensive care
PMID: 31905235 DOI: 10.1093/cid/ciaa007
Schwartz IS[SUP]1[/SUP], Friedman DZP[SUP]1[/SUP], Zapernick L[SUP]1[/SUP], Dingle TC[SUP]2[/SUP], Lee N[SUP]1[/SUP], Sligl W[SUP]1,[/SUP][SUP]3[/SUP], Zelyas N[SUP]2[/SUP], Smith SW[SUP]1[/SUP].
[h=3]Author information[/h] 1 Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta. 2 Department of Laboratory Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta and Alberta Public Laboratories, Alberta Health Services. 3 Department of Critical Care Medicine, University of Alberta.
[h=3]Abstract[/h] Invasive pulmonary aspergillosis (IPA) complicated 7.2% of patients with influenza-associated respiratory failure in Edmonton, Alberta, from 2014-2019, ranging from 0-23.1% in different influenza seasons. Disease outcomes ranged from survival without therapy to death despite antifungals. Clinician vigilance, longitudinal local surveillance, and refined criteria to identify patients requiring therapy are needed.
? The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.
[h=4]KEYWORDS:[/h] Aspergillus ; aspergillosis; emerging infections; influenza; intensive care
PMID: 31905235 DOI: 10.1093/cid/ciaa007